| Title | [Fixed combination perindopril-amlodipine (Coveram) in the treatment of hypertension and coronary heart disease] | | Author(s) | Scheen AJ, Krzesinski JM | | Institution | Université de Liège. | | Source | Rev Med Liege 2009 Apr; 64(4):223-7. | | Abstract | Coveram is a new fixed combination of an angiotensin converting enzyme inhibitor, perindopril, and a calcium antagonist, amlodipine. This new medication is indicated for the treatment of arterial hypertension and/or stable coronary heart disease. Such fixed combination of two molecules that have been extensively evaluated according to evidence-based medicine offers the advantage of an excellent efficacy, associated with a good tolerance profile, and favours patient's compliance. The marketing of different formulations of Coveram combining various dosages allows easy adjustment and titration of each of the components according to the individual patient's characteristics. | | Language | fre | | Pub Type(s) | English Abstract
Journal Article
| | PubMed ID | 19514543 |
|
